All Insights Report Future Of Pharma: Evolving Commercial Models – Part 1

    Future Of Pharma: Evolving Commercial Models – Part 1

    Commercial Models

    Future Of Pharma: Evolving Commercial Models – Part 1

    Findings from Axtria’s industry survey on how the commercial models will evolve in the future.

    Download Report
    Future Of Pharma: Evolving Commercial Models – Part 1

    The pharmaceutical industry is in a state of flux with the increasing influence of payers, pressure from the government with restricted healthcare budgets, and the rise of multi-channel marketing. Over 40%1 of physicians are restricting access to reps and almost 50%2 of physicians spend 4-5 hours a day on their digital devices conducting research and engaging with peers.

    The increasing focus on pricing, declining access to physicians and the evolving role of sales and marketing, has compelled pharma companies to reassess their commercial strategy and operations.

    Axtria conducted interviews with several senior pharma commercial operations leaders to seek their views on the potential implications of the industry challenges on business operations, sales and marketing objectives and how the commercial models will evolve in the future.

    In the first part of this two-part series, we present our findings from the survey. In the second report, we will share actionable recommendations on what can be done to address the gaps identified.

    Contact us at insights@axtria.com with any questions.

    Complete the brief form to download the white paper

    Recommended insights

    Evolving Commercial Models Report Part 1

    Article

    The Evolution of Pharma Field Force Deployment and Targeting

    Evolving Commercial Models Report Part 1

    Case Study

    A Custom-Built Hierarchy Management System To Facilitate On-Demand Commercial Analytics And AI/ML Models

    Evolving Commercial Models Report Part 1

    White Paper

    The Future Of The Pharma Commercial Model - Embracing The Customer Experience